Adenoviral Transfer of the Murine Oncostatin M Gene Suppresses Dextran-Sodium Sulfate-Induced Colitis

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Interferon and Cytokine Research

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/107999003765027393PMID 12856331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial transport and gut barrier function in colitis

  2003cited by this paper
• Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice1

  2003cited by this paper
• Secretion of Oncostatin M by Infiltrating Neutrophils: Regulation of IL-6 and Chemokine Expression in Human Mesothelial Cells1

  2002cited by this paper
• Tapeworm Infection Reduces Epithelial Ion Transport Abnormalities in Murine Dextran Sulfate Sodium-Induced Colitis

  2001cited by this paper
• Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.

  2001cited by this paper
• Exclusive neutrophil recruitment with oncostatin M in a human system.

  2001cited by this paper
• Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.

  2001cited by this paper
• The Prevention and Treatment of Murine Colitis Using Gene Therapy with Adenoviral Vectors Encoding IL-101

  2001cited by this paper
• Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

  2000cited by this paper
• Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

  2000cited by this paper
• Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity.

  2000influential reference
• IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis1

  2000cited by this paper
• Non-redundant Signal Transduction of Interleukin-6-type Cytokines

  2000cited by this paper
• Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis.

  2000cited by this paper
• Characterisation of Acute Murine Dextran Sodium Sulphate Colitis: Cytokine Profile and Dose Dependency

  2000cited by this paper
• Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine1

  2000cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• Tumor necrosis factor: biology and therapeutic inhibitors.

  2000influential reference
• Cathepsin K and the design of inhibitors of cathepsin K.

  2000cited by this paper
• Interleukin 10 gene transfer prevents experimental colitis in rats

  2000cited by this paper
• Adenovirus Vector Expressing Mouse Oncostatin M Induces Acute-Phase Proteins and TIMP-1 Expression In Vivo in Mice

  1999influential reference
• Cardiotrophin-1 attenuates endotoxin-induced acute lung injury.

  1999cited by this paper
• Interferon‐gamma (IFN‐γ)‐ and tumour necrosis factor (TNF)‐induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)‐induced colitis in mice

  1999cited by this paper
• Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen.

  1999cited by this paper
• Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.

  1999cited by this paper
• Regulation of inflammatory responses by oncostatin M.

  1999cited by this paper
• Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury

  1999cited by this paper
• Adenovirus-Mediated Transduction of Intestinal Cells In Vivo

  1998cited by this paper
• Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice.

  1998cited by this paper
• Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

  1998cited by this paper
• Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

  1997cited by this paper
• Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium.

  1997cited by this paper
• Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.

  1997cited by this paper
• IL-6 and APPs: anti-inflammatory and immunosuppressive mediators.

  1997cited by this paper
• Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.

  1996cited by this paper
• Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts.

  1996cited by this paper
• Interleukin 4 or oncostatin M induces a prolonged increase in P- selectin mRNA and protein in human endothelial cells

  1996cited by this paper
• Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs.

  1995cited by this paper
• Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.

  1994cited by this paper
• Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

  1994cited by this paper
• Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M.

  1993cited by this paper
• Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function.

  1993cited by this paper
• Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites.

  1993cited by this paper
• Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture.

  1993cited by this paper
• Regulation of IL-6 expression by oncostatin M.

  1991cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

  1990cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

  1990cited by this paper
• Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease.

  1990cited by this paper
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage

  1981influential reference
• Rocket Immunoelectrophoresis

  1973cited by this paper

• Gene Therapy in Crohn’s Disease: Current Preclinical Challenges and Future Translational Avenues

  2025cites this paper
• Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts.

  2024cites this paper
• Oncostatin M: Risks and benefits of a Novel Therapeutic Target for Atherosclerosis.

  2022cites this paper
• New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology

  2021cites this paper
• Drug delivery to the inflamed intestinal mucosa- targeting technologies and human cell culture models for better therapies of IBD.

  2021cites this paper
• Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease

  2020cites this paper
• Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)

  2019cites this paper
• Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines

  2019cites this paper
• The oncostatin M‐stromal cell axis in health and disease

  2018influential citation
• Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease

  2017cites this paper
• A role for oncostatin M in inflammatory bowel disease

  2017cites this paper
• Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy

  2016cites this paper
• Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.

  2015cites this paper
• Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members

  2014cites this paper
• Focused Examination of the Intestinal lamina Propria Yields Greater Molecular Insight into Mechanisms Underlying SIV Induced Immune Dysfunction

  2012cites this paper
• Reduced Severity of a Mouse Colitis Model with Angiotensin Converting Enzyme Inhibition

  2007cites this paper
• Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats.

  2007cites this paper
• Epithelial transport and gut barrier function in colitis

  2003cites this paper